Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

206.95 +0.04 (+0.02%)
Official Closing Price Updated: 7:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,084,018
Open 206.91
Bid (Size) 206.00 (100)
Ask (Size) 208.50 (100)
Prev. Close 206.91
Today's Range 206.37 - 207.50
52wk Range 140.68 - 215.19
Shares Outstanding 2,628,679,824
Dividend Yield 2.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Johnson & Johnson Near Year High ↗
Johnson & Johnson is nearing its 52-week high, driven by strong momentum and positive news, raising expectations for its upcoming earnings report amidst heightened sensitivity to market trends. 
Via Talk Markets
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Right Now ↗
These income stocks could be great buys to add to your portfolio. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
N/A
N/A
1 Month
+0.8%
+0.8%
3 Month
+11.2%
+11.2%
6 Month
+33.0%
+33.0%
1 Year
+43.1%
+43.1%

More News

Read More
News headline image
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
News headline image
S&P 500 Eyes 7,000 Milestone: Technical Breakout Sets the Stage for a High-Stakes 2026
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Palantir Shares Retreat to $180.80 as Hawkish Fed Minutes and Institutional Rebalancing Cool Year-End Rally
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Trillion-Dollar Shuffle: How Year-End Institutional Rebalancing is Fueling Late-December Volatility
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
News headline image
The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Hunterbrook Capital Bets Big on Achieve Life Sciences: Why a 'Toxic Tree' Could Disrupt the Multi-Billion Dollar Smoking Cessation Market
Via MarketMinute
Topics Product Recall
News headline image
The S&P 500 Seesaw: Analyzing IVV’s Year-End Turbulence After a Record-Breaking 2025
Via MarketMinute
Topics ETFs Economy Retirement
News headline image
Wall Street Stumbles at the Finish Line: S&P 500 and Nasdaq Fight to Break 3-Day Slide Amid Year-End Rebalancing
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Could These 3 "Recession-Proof" Dividend Stocks Surge 100% by 2031? ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Santa Claus Stumble: Markets Pivot from Record Highs to Year-End Consolidation
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Price of Prosperity: Navigating the S&P 500’s Historic Valuation Peak as 2026 Dawns
Via MarketMinute
Topics Artificial Intelligence Bonds Earnings
News headline image
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
From Johnson & Johnson
Via Business Wire
News headline image
Blue-Chip Bull Run: Dow Jones Eyes 50,000 Milestone Amidst 2026 Technical Pivot
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Johnson & Johnson Terminates Experimental Eczema Drug Study After It Fails To Show Benefit ↗
Via Stocktwits
News headline image
Johnson & Johnson Halts Atopic Dermatitis Study After Interim Analysis Miss ↗
Via Benzinga
News headline image
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
Via PredictStreet
Topics Economy Emissions Product Recall
News headline image
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
Via MarketMinute
Topics Economy Intellectual Property
News headline image
Barking Back: Why the 'Dogs of the Dow' 4-Stock Play is the Contrarian Bet for 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
This Dividend ETF Could Quietly Make You a Multimillionaire Over Time ↗
Via The Motley Fool
Topics ETFs
News headline image
Top 5 US Healthcare Stocks By Market Value ↗
Via Stocktwits

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 206.95
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 12/31/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 544.01B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 544B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.